Skip to main content
. 2014 Mar 10;25(2):72–84. doi: 10.1089/humc.2013.208

FIG. 2.

FIG. 2.

No abnormal changes in hematology in NHP receiving a systemic rAAV9-hNAGLU vector delivery. (a) Group 1: 1E13 vg/kg group. (b) Group 2: 2E13 vg/kg group. Blood samples were assayed for hematology before and after the vector delivery. *Subject with high preexisting anti-AAV9 antibodies. RBC, red blood cell count; WBC, white blood cell count.